ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 38 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 12

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 3, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	3,083	$59.24	$182,634.73	-0.3%	-16.5%	-55.8%
May 3, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	8,420	$59.24	$498,783.83	-4.4%	-16.5%	-55.8%
May 3, 2021	Sun Anthony Y81	President &CEO	Sell	26,794	$59.32	$1,589,505.61	-0.5%	-16.5%	-55.8%
Apr 13, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	3,810	$45.00	$171,450.00	-7.0%	+11.3%	-41.0%
Apr 6, 2021	Gallagher Cam81	Director	Sell	28,369	$43.40	$1,231,238.44	-1.0%	+8.8%	+13.6%
Apr 6, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	25,211	$43.40	$1,094,031.66	-0.5%	+8.8%	+13.6%
Apr 5, 2021	Johnson David Michael59	Director	Sell	12,897	$43.50	$561,020.79	-12.7%	+7.0%	+12.5%
Apr 5, 2021	Epperly Melissa B,72	Chief Financial Officer	Sell	17,107	$43.39	$742,323.38	-1.6%	+7.0%	+12.5%
Apr 5, 2021	Sun Anthony Y81	President &CEO	Sell	64,562	$43.43	$2,803,799.56	-0.6%	+7.0%	+12.5%
Apr 1, 2021	Bunker Kevin D.78	Chief Operating Officer	Sell	4,210	$43.45	$182,916.55	-2.5%	+22.8%	+7.5%

← PrevPage 12Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC